Načítá se...
Endocrine therapy combined with targeted therapy in hormone receptor-positive metastatic breast cancer
Increasing numbers of targeted drugs are used in hormone receptor (HR)-positive metastatic breast cancer (MBC) to overcome or delay resistance to endocrine therapy. This study will systemically review the progress made in endocrine therapy combined with targeted therapy in the treatment of HR-positi...
Uloženo v:
| Vydáno v: | Chin Med J (Engl) |
|---|---|
| Hlavní autoři: | , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Lippincott Williams & Wilkins
2020
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7546887/ https://ncbi.nlm.nih.gov/pubmed/32852380 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/CM9.0000000000000923 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|